Filing Details
- Accession Number:
- 0001209191-15-054008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-16 20:14:59
- Reporting Period:
- 2015-06-15
- Filing Date:
- 2015-06-16
- Accepted Time:
- 2015-06-16 20:14:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178879 | Amicus Therapeutics Inc | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1593352 | Julie Yu | C/O Amicus Therapeutics Cranbury NJ 08512 | Vp Clinical Ops & Data Mgmt | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-06-15 | 8,195 | $14.17 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2014.
- This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.95 to $14.53. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.